Dr Matetzky graduated cum laude from the Sackler School of Medicine, Tel Aviv University. He continued his studies specializing in Internal Medicine and Cardiology at the Sheba Medical Center. From 1998 to 2001 Dr Matetzky specialized in Intensive Care Cardiology at Cedars Sinai in Los Angeles USA. During his fellowship Prof Matetzky researched myocardial infarcts and atherosclerosis in the young and the correlation between coagulation disturbance and myocardial infarction. His fellowship included laboratory work as a research team member of one of the renowned laboratories in this field at UCLA - Atherosclerosis Research Center, especially in Atherosclerotic Plaque thrombogenecity. Dr Matetzky has an academic track professorship in Cardiology and Internal Medicine from the Tel Aviv University. Currently Dr Matetzky is the Director of Cardiovascular Hospitalization and the Cardiac Intensive Care Unit, as well as in recent years being appointed Deputy Director of the Division of Cardiology in the Sheba Medical Center, Israel. Dr Matetzky established a Clinic for premature infarcts/atherosclerosis in the Sheba Medical Center dealing with treatment for young cardiac patients with emphasize on diagnosis and treatment of hypercoagulable states. In 2016 he set up a Chest Pain Center (CPC) in the Sheba Medical Center to identify and treat patients suffering from chest pain and suspected coronary disease. After evaluating over 15,000 patients with suspected coronary events the unit was enlarged to include a Fast Track Evaluation for patients with low risk pulmonary emboli and DVT as an innovative approach to providing a remarkable service to treat these patients at Sheba. Dr Matetzky is a member of the Medical Board of Magen David Adom (Israeli national EMS) and is senior consulting cardiologist to the Israeli Airforce holding the position of Lieutenant Colonel. Over the last decade Prof Matetzky has fulfilled number of positions in the Israel Heart Society. Among them he was head of the working group for intensive cardiac care (ACCA) and currently is head of the Working Group for Cardiovascular Pharmacotherapy. Within the framework of his duties Prof Matetzky was responsible for the Acute Coronary Syndrome Israeli Survey (ACSIS). Prof Matetzky was a co-author of the Guidelines for the Israel Heart Society. Prof Matetzky is a member of many professional societies: IHS, ESC and ISTH as well as professional forums such as the Pulmonary Embolism Expert Forum (PEEF) and ICHOM (International Consortium for Health Outcomes Measurement). In this framework he initiated the PROM program for cardiology patients at Sheba. Prof Matetzky is a member of the organizing committee of several local and internationl conferences including ICI and ACCA. He was awarded the prestigious Mirowsky Prize for excellence in cardiology. Prof Matetzky is an active lecturer and teacher in the Sackler Faculty of Medicine at Tel Aviv University. Prof Matetzky has published over 150 manuscripts in prestigious scientific journals, including many manuscripts in the field of platelet function in coronary patients and their response to anti-platelet agents as well as laboratory studies on basic science in the field of atherothrombosis. Main topics of Prof Matetzky's research include clinical studies in AMI patients, treatment of acute coronary episodes, and specifically platelet function in patients with ACS, platelet responsiveness to anti- platelet agents in ACS and post PCI as well as ex-vivo and laboratory studies platelets function. Further research topics include the pathogenesis of premature coronary events and coagulation disorders. Recently Prof Matetzky has been involved in research in the field of vascular medicine, especially regarding the significance of PAD in coronary patients and predictors and pathogenesis of pulmonary emboli. Most recently Prof Matetzky initiated and now heads a large prospective registry of hospitalized PE patients and is involved in a number of studies on the prognostication and treatment PE patients.